ZA200700651B - 3-substituted-5-and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase - Google Patents
3-substituted-5-and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinaseInfo
- Publication number
- ZA200700651B ZA200700651B ZA200700651A ZA200700651A ZA200700651B ZA 200700651 B ZA200700651 B ZA 200700651B ZA 200700651 A ZA200700651 A ZA 200700651A ZA 200700651 A ZA200700651 A ZA 200700651A ZA 200700651 B ZA200700651 B ZA 200700651B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitors
- substituted
- carboxylic acid
- acid amides
- casein kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60338004P | 2004-08-19 | 2004-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200700651B true ZA200700651B (en) | 2008-09-25 |
Family
ID=35311279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200700651A ZA200700651B (en) | 2004-08-19 | 2007-01-22 | 3-substituted-5-and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase |
Country Status (27)
Country | Link |
---|---|
US (2) | US7629376B2 (xx) |
EP (1) | EP1794122B1 (xx) |
JP (1) | JP4843608B2 (xx) |
KR (2) | KR20130038409A (xx) |
CN (1) | CN101006055B (xx) |
AR (1) | AR050919A1 (xx) |
AT (1) | ATE508112T1 (xx) |
AU (1) | AU2005277523B2 (xx) |
BR (1) | BRPI0514380A (xx) |
CA (1) | CA2577667C (xx) |
DE (1) | DE602005027858D1 (xx) |
GT (1) | GT200500214A (xx) |
HK (1) | HK1105196A1 (xx) |
IL (1) | IL181156A (xx) |
JO (1) | JO2724B1 (xx) |
MA (1) | MA28863B1 (xx) |
MX (1) | MX2007001382A (xx) |
NO (1) | NO20071466L (xx) |
NZ (1) | NZ552800A (xx) |
PA (1) | PA8642901A1 (xx) |
PE (1) | PE20060498A1 (xx) |
RU (1) | RU2369599C2 (xx) |
SV (1) | SV2006002192A (xx) |
TW (1) | TWI357897B (xx) |
UY (1) | UY29078A1 (xx) |
WO (1) | WO2006023467A1 (xx) |
ZA (1) | ZA200700651B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010092660A1 (ja) * | 2009-02-12 | 2010-08-19 | 株式会社ファルマデザイン | カゼインキナーゼ1δ及びカゼインキナーゼ1ε阻害剤 |
CA2758974A1 (en) * | 2009-04-17 | 2010-10-21 | Cylene Pharmaceuticals, Inc. | Method of treating disorders associated with protein kinase ck2 activity |
NZ702618A (en) | 2012-06-27 | 2016-12-23 | 4Sc Discovery Gmbh | Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and cns disorders |
EP3746438A1 (en) | 2018-01-29 | 2020-12-09 | Cadila Healthcare Limited | Heterocyclic compounds useful as antibacterial agents |
WO2022006377A2 (en) * | 2020-07-02 | 2022-01-06 | Mbq Pharma | Heterocyclic inhibitors of rho gtpases for the treatment of disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5296471A (en) | 1992-12-22 | 1994-03-22 | Glycomed Incorporated | Method for controlling o-desulfation of heparin and compositions produced thereby |
ATE322016T1 (de) | 1999-06-08 | 2006-04-15 | Aventis Pharma Inc | Screeningsverfahren zur änderung zirkadiane- rhythmus-eiweisse |
WO2004014851A2 (en) * | 2002-08-09 | 2004-02-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
EP1747220B1 (en) * | 2003-12-11 | 2009-04-15 | Aventis Pharmaceuticals Inc. | Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon |
-
2005
- 2005-07-24 JO JO2005108A patent/JO2724B1/en active
- 2005-08-09 GT GT200500214A patent/GT200500214A/es unknown
- 2005-08-10 SV SV2005002192A patent/SV2006002192A/es active IP Right Grant
- 2005-08-16 RU RU2007109783/04A patent/RU2369599C2/ru not_active IP Right Cessation
- 2005-08-16 NZ NZ552800A patent/NZ552800A/en not_active IP Right Cessation
- 2005-08-16 JP JP2007527928A patent/JP4843608B2/ja not_active Expired - Fee Related
- 2005-08-16 KR KR1020137005469A patent/KR20130038409A/ko not_active Application Discontinuation
- 2005-08-16 BR BRPI0514380-2A patent/BRPI0514380A/pt not_active IP Right Cessation
- 2005-08-16 CN CN2005800284407A patent/CN101006055B/zh active Active
- 2005-08-16 EP EP05786210A patent/EP1794122B1/en active Active
- 2005-08-16 WO PCT/US2005/029053 patent/WO2006023467A1/en active Application Filing
- 2005-08-16 DE DE602005027858T patent/DE602005027858D1/de active Active
- 2005-08-16 AT AT05786210T patent/ATE508112T1/de not_active IP Right Cessation
- 2005-08-16 AU AU2005277523A patent/AU2005277523B2/en not_active Ceased
- 2005-08-16 CA CA2577667A patent/CA2577667C/en not_active Expired - Fee Related
- 2005-08-16 KR KR1020077003922A patent/KR20070043012A/ko active IP Right Grant
- 2005-08-16 MX MX2007001382A patent/MX2007001382A/es active IP Right Grant
- 2005-08-16 AR ARP050103442A patent/AR050919A1/es not_active Application Discontinuation
- 2005-08-17 PE PE2005000955A patent/PE20060498A1/es not_active Application Discontinuation
- 2005-08-19 TW TW094128283A patent/TWI357897B/zh not_active IP Right Cessation
- 2005-08-19 UY UY29078A patent/UY29078A1/es unknown
- 2005-08-19 PA PA20058642901A patent/PA8642901A1/es unknown
-
2007
- 2007-01-22 ZA ZA200700651A patent/ZA200700651B/xx unknown
- 2007-02-04 IL IL181156A patent/IL181156A/en not_active IP Right Cessation
- 2007-02-13 US US11/674,385 patent/US7629376B2/en active Active
- 2007-03-14 MA MA29757A patent/MA28863B1/fr unknown
- 2007-03-19 NO NO20071466A patent/NO20071466L/no not_active Application Discontinuation
- 2007-09-27 HK HK07110474.7A patent/HK1105196A1/xx not_active IP Right Cessation
-
2008
- 2008-11-12 US US12/269,216 patent/US7923466B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200704888B (en) | Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases | |
IL198487A0 (en) | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors | |
ZA200610593B (en) | Diphenylimidazopyrimidine and -imidazole amines as inhibitors of ß-secretase | |
TWI372149B (en) | Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase iε | |
ZA200704106B (en) | Inhibitors of c-fms kinase | |
IL198398A0 (en) | 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors | |
EP1931205A4 (en) | TRANSGLUTAMINASE INHIBITORS AND METHOD OF USE THEREOF | |
PT2004155T (pt) | Inibidores de agregação proteica | |
IL179613A0 (en) | Compounds and compositions as protein kinase inhibitors | |
PL1713806T3 (pl) | Związki i kompozycje jako inhibitory kinaz białkowych | |
EP1756092A4 (en) | NEW INHIBITORS OF RHO-KINASEN | |
IL186526A0 (en) | Substituted amide derivatives as protein kinase inhibitors | |
IL182687A0 (en) | Compounds and compositions as protein kinase inhibitors | |
HK1129298A1 (en) | Dihydrodiazepines useful as inhibitors of protein kinases | |
PL377825A1 (pl) | Diaminotriazole użyteczne jako inhibitory kinaz białkowych | |
PL1811998T3 (pl) | Triazole użyteczne jako inhibitory kinaz białkowych | |
GB0421525D0 (en) | Inhibitors of protein kineses | |
IL194699A0 (en) | Tetrahydropteridines useful as inhibitors of protein kinases | |
EP1765820A4 (en) | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF PROTEIN KINASES | |
ZA200806871B (en) | Dihydrodiazepines useful as inhibitors of protein kinases | |
EP1877424A4 (en) | INHIBITORS OF PROTEIN KINASES AND USES THEREOF | |
IL182735A0 (en) | Inhibitors of c-fms kinase | |
HK1105196A1 (en) | 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i | |
ZA200703130B (en) | Compounds and compositions as protein kinase inhibitors | |
PL1753720T3 (pl) | Proces wytwarzania peryndoprylu i jego soli |